Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Adenoma, Islet Cell × Injections × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Triple Negative Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Neuroendocrine Tumors 1 Intestinal Neoplasms 1 Hematopoietic Recovery 1 HER2 Low Breast Carcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Adenoma, Islet Cell 1

Interventions

PM 01183 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07121478 2025-10-01

Patients With High-grade Pancreatic Neuroendocrine Tumors

National Cancer Center, Korea

Phase 2 Enrolling by invitation

Adenoma, Islet Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡